ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $503,750 | +1547.2% | 31,000 | +1774.2% | 0.01% | +800.0% |
Q1 2024 | $30,582 | -85.8% | 1,654 | -75.9% | 0.00% | -66.7% |
Q4 2023 | $215,287 | +153.2% | 6,876 | +68.5% | 0.00% | 0.0% |
Q3 2023 | $85,027 | -68.5% | 4,080 | -63.8% | 0.00% | -66.7% |
Q2 2023 | $269,989 | +402868.7% | 11,273 | +218.8% | 0.01% | +350.0% |
Q1 2023 | $67 | -32.3% | 3,536 | -43.5% | 0.00% | -50.0% |
Q4 2022 | $99 | -100.0% | 6,256 | -69.7% | 0.00% | -20.0% |
Q3 2022 | $337,000 | -10.6% | 20,613 | -22.9% | 0.01% | -37.5% |
Q2 2022 | $377,000 | +518.0% | 26,752 | +961.2% | 0.01% | +700.0% |
Q1 2022 | $61,000 | -80.9% | 2,521 | -81.6% | 0.00% | -83.3% |
Q4 2021 | $320,000 | -5.0% | 13,678 | -32.6% | 0.01% | -33.3% |
Q3 2021 | $337,000 | +104.2% | 20,304 | +200.7% | 0.01% | +125.0% |
Q2 2021 | $165,000 | +223.5% | 6,752 | +244.5% | 0.00% | +300.0% |
Q1 2021 | $51,000 | -95.4% | 1,960 | -90.5% | 0.00% | -97.1% |
Q4 2020 | $1,098,000 | +652.1% | 20,528 | +479.6% | 0.03% | +1600.0% |
Q3 2020 | $146,000 | -83.8% | 3,542 | -80.9% | 0.00% | -94.6% |
Q2 2020 | $900,000 | +213.6% | 18,576 | +176.6% | 0.04% | +54.2% |
Q4 2019 | $287,000 | +124.2% | 6,715 | +88.3% | 0.02% | +166.7% |
Q3 2019 | $128,000 | – | 3,567 | +118800.0% | 0.01% | – |
Q2 2019 | $0 | – | 3 | -84.2% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 19 | -100.0% | 0.00% | -100.0% |
Q3 2018 | $877,000 | – | 42,230 | +324746.2% | 0.06% | – |
Q2 2018 | $0 | -100.0% | 13 | -99.8% | 0.00% | -100.0% |
Q1 2018 | $154,000 | +755.6% | 6,839 | +971.9% | 0.01% | +550.0% |
Q2 2017 | $18,000 | -65.4% | 638 | -57.6% | 0.00% | -60.0% |
Q1 2017 | $52,000 | +23.8% | 1,504 | +4.0% | 0.01% | 0.0% |
Q4 2016 | $42,000 | +100.0% | 1,446 | +121.4% | 0.01% | +150.0% |
Q3 2016 | $21,000 | -84.6% | 653 | -84.5% | 0.00% | -84.6% |
Q2 2016 | $136,000 | +1842.9% | 4,205 | +1529.8% | 0.01% | +1200.0% |
Q1 2016 | $7,000 | -82.1% | 258 | -76.6% | 0.00% | -83.3% |
Q4 2015 | $39,000 | +1850.0% | 1,101 | +1593.8% | 0.01% | – |
Q3 2015 | $2,000 | -98.6% | 65 | -98.2% | 0.00% | -100.0% |
Q2 2015 | $148,000 | +492.0% | 3,522 | +354.5% | 0.01% | +333.3% |
Q1 2015 | $25,000 | +525.0% | 775 | +510.2% | 0.00% | – |
Q4 2014 | $4,000 | -93.9% | 127 | -95.2% | 0.00% | -100.0% |
Q3 2014 | $66,000 | +1550.0% | 2,653 | +1390.4% | 0.01% | +600.0% |
Q2 2014 | $4,000 | +33.3% | 178 | +25.4% | 0.00% | – |
Q1 2014 | $3,000 | -99.1% | 142 | -98.8% | 0.00% | -100.0% |
Q3 2013 | $329,000 | +722.5% | 11,960 | +444.9% | 0.04% | +1066.7% |
Q2 2013 | $40,000 | – | 2,195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |